Myriad Genetics to acquire diagnostic company Crescendo
Myriad Genetics has entered into a definitive agreement to acquire inflammatory and autoimmune diagnostics company Crescendo Bioscience for $270 million.
Baker & McKenzie welcomes pharma lawyer
Law firm Baker & McKenzie has hired pharmaceutical lawyer Julian Thurston as a consultant in its global pharmaceutical and healthcare industry group.
Powell Gilbert adds medical doctor to practice
UK IP law firm Powell Gilbert has appointed solicitor and medical doctor Tess Waldron as an associate.
Non-profit celebrates ear implant win
A US medical research foundation has received about $131.2 million in damages after a jury found that two of its patents covering cochlear implants were infringed.
Covidien wins patent suit against Johnson & Johnson owned company
Healthcare company Covidien PLC has been told it did not infringe patents belonging to a Johnson & Johnson-owned company through using its ultrasonic dissection device.
FDA approval adds new life to Copaxone
On January 28, Teva announced that the FDA had approved its supplemental new drug application for a new formulation of its biggest selling drug Copaxone.
Generic KRKA to receive damages in Nexium case
The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged.
Blank Rome hires patent litigator
Law firm Blank Rome LLP has expanded its IP litigation group with the appointment of Christopher Hu.
Johnson & Johnson named top pharmaceutical company for social media
Johnson & Johnson has been named the most effective pharmaceutical company on social media, in a new report.
India considers more compulsory licences
A government-appointed panel in India is preparing to evaluate more patented drugs for local generic pharmaceutical companies to mimic, according to reports.
